Clinical trial
12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C…
NCT00069511 · United Therapeutics, Industry · Unknown status
Key facts
| NCT number | NCT00069511 |
|---|---|
| Title | 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy. |
| Lead sponsor | United Therapeutics, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | UT-231B |
| Enrollment | 72 |
| Start date | Jul 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Sep 30, 2003 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: